Quick Links
Past Events

Credit Designation

Physicians’ Education Resources®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

Medical Crossfire: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum

Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum

November 10, 2017
Scientific Session: 1:40 PM – 3:10 PM

New York Marriott Marquis

Julliard Complex (5th Floor)
1535 Broadway
New York, NY 10036


Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum will update oncology healthcare professionals involved in the treatment of patients with lung cancer by providing expert guidance, interpretation, and opinions on the importance and impact of liquid biopsy testing through multiple lines of therapy. This activity features 4 modules, which will present multiple expert points-of-view on this rapidly evolving area of molecular testing. In Module 1, the role of tumor genotyping in treatment decision making will be discussed, as well as the strengths and weaknesses of conventional tissue-based testing. Module 2 will outline the scientific basis for liquid-based molecular testing, including current data on the levels of concordance between liquid- and tissue-based genotyping. Module 3 will incorporate case-based discussion on the real-world application of liquid biopsies, including issues regarding turnaround time, sensitivity, and specificity. Module 4 will address outstanding questions and potential future applications of liquid-based biopsies.

Target Audience:

This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer, as well as nurse practitioners and nurses. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer will be invited to participate.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  • Compare the relative strengths and limitations of liquid biopsy against those of conventional tissue biopsy
  • Identify the scientific foundations of liquid biopsy technology
  • Contrast available and emerging testing technologies with respect to sensitivity, specificity, and clinical applications for patients with lung cancer
  • Appraise clinical evidence pertaining to specific testing modalities that may help to individualize treatment protocols for patients with lung cancer

Activity Chair

Benjamin Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC

Become a Member

Forgot Password?
Calendar of Events
Filter By